Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 46 | History Defined

The FDA Is Investigating Rare Catastrophic Anesthesia Reactions Tied to a Mitochondrial Variant

The FDA is investigating rare, severe neurologic reactions to sevoflurane in patients carrying a maternally inherited mitochondrial variant.

Medical Daily · Jul 30

No, there's no proof sunscreen increases cancer risk

Social media posts are pointing to a study of more than 470,000 people to argue that sunscreen increases the risk of skin cancer. However, the study didn't examine whether sunscreen is dangerous, and its findings have been largely distorted.

France 24 · Jul 30

‘It’s a peptide wild west’: how RFK Jr is clearing way for a market of untested drugs

A century ago, compounding pharmacies helped people get bespoke drugs. Now these less-regulated businesses are fueling the peptide boom

The Guardian - US · Jul 30

From analysis to the latest developments in health,
read the most diverse news in one place.

Cancer Patients Should Not Stop Treatment Over This Chemotherapy Recall, but One Question Is Worth Asking

Three lots of injectable cyclophosphamide were recalled for steel particulate. No one should stop treatment. Here is what to ask your infusion center.

Medical Daily · Jul 30

Active U.S. Drug Shortages Have Risen to 223, and Two Official Counts Disagree on the Scale

Pharmacists count 223 active US drug shortages while the FDA tracks far fewer. Here is why the two numbers differ and what it means for patients.

Medical Daily · Jul 30

The FDA's Cancer Drug Advisory Panel Has Lost Its Acting Chair and Carries Multiple Vacancies

The acting chair of the FDA's cancer drug advisory committee has departed at the end of his term, leaving ODAC with several open seats.

Medical Daily · Jul 30

The New Tylenol and Naproxen Pill Creates Two Different Ways to Double Up by Accident

The FDA approved the first OTC acetaminophen and naproxen combination pill. It creates two separate ways to accidentally exceed a daily limit.

Medical Daily · Jul 30

Read news from The Economist, FT, and more,
with one subscription

Judge Says the FDA Never Explained Why Mifepristone Prescriber Certification Was Necessary

A federal judge ruled the FDA failed to justify its 2023 mifepristone REMS requirements. The rules stay in effect while the agency reconsiders.

Medical Daily · Jul 30

FDA Sets the Testing Standards Generic Weight Loss Injections Must Meet Before Approval

The FDA published 17 revised draft guidances setting testing expectations for generic peptide injections, including semaglutide and tirzepatide.

Medical Daily · Jul 30

FDA Approves a Blood Test for Colorectal Cancer Screening That Misses Most Precancerous Growths

The FDA approved SimpleScreen CRC, a blood test for colorectal cancer screening. It detects cancer well but finds few precancerous lesions.

Medical Daily · Jul 30

The New ADHD Drug Carries Two Boxed Warnings and Will Be a Controlled Substance

The new ADHD drug Simtriyo carries two boxed warnings, pediatric suicidality monitoring, and CNS stimulant status pending DEA scheduling.

Medical Daily · Jul 30

FDA Reviewers Say Melanoma Trial Data Cannot Be Verified as Advisers Weigh a Third Review

FDA reviewers say Replimune's RP1 melanoma data confound interpretation. Advisers meet July 30 ahead of an August 2 decision on a third review.

Medical Daily · Jul 30

Duchenne Families Face a Three-Week Wait After FDA Advisers Rejected the Heart Therapy Evidence

FDA advisers voted 9-3 that evidence for dermaicell falls short for Duchenne cardiomyopathy. The FDA decides by August 22. What families should know.

Medical Daily · Jul 30

Levothyroxine: Thyroid medication recalled across US due to low potency

Major Pharmaceuticals is voluntarily recalling a number of Levothyroxine Sodium Tablets due to subpotency, the US Food and Drug Administration (FDA) has said. According to the government agency's Enforcement Report, the recall was initiated on July 13 and affects pills distributed by Major Pharmaceuticals and Cardinal Health. The recalled products…

The Independent UK · Jul 30

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times · Jul 30

Bye-bye painful dentist visit: A simple liquid could stop tooth decay; no drilling or injections needed for many cavities

A major US clinical trial has found that silver diamine fluoride, a liquid painted onto cavities in seconds, stopped tooth decay in more than half of treated baby teeth without any drilling, injections, or sedation. Researchers say the findings could support FDA approval and transform how cavities are treated, especially…

The Economic Times · Jul 30

Bombay HC restores FDA-suspended Navi Mumbai hotel's licence, says 'we are in India, need a realistic approach'

The Bombay High Court quashed an FDA order suspending a hotel's food license. This action followed a surprise inspection which found only two insects. The court noted the hotel had a 95 percent hygiene compliance score. Authorities were directed to immediately restore the hotel's FSSAI license. The FDA must now…

The Economic Times · Jul 30

No vada pav, samosa, chocolates near schools anymore: Maharashtra bans junk food within a 50-metre radius; check list of banned items & penalties

Maharashtra FDA has banned junk food sales within fifty meters of schools. This move aims to promote healthier eating habits among students statewide. Principals and school management will face action for any violations of this new rule. Inspections will begin soon across the state to ensure strict compliance. The department…

Medical Daily · Jul 30

Regulators Tell Doctors to Limit Anticholinergic Drugs in Older Adults, While Saying the Dementia Question Remains Open

UK regulators reviewed 17 studies on bladder anticholinergics and dementia. The evidence could not confirm or exclude a causal link.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Jul 30

FDA Advisers Meet Thursday on a Melanoma Therapy the Agency Says It Cannot Interpret

FDA advisers review Replimune's melanoma therapy Thursday. The agency's own briefing documents question the interpretability of the trial data.

Medical Daily · Jul 29

FDA Clears a Non-Invasive Test That Estimates a Heart Pressure Normally Measured with a Catheter

The FDA cleared CorVista's PCWP add-on, a non-invasive AI test estimating a heart pressure usually measured by catheter.

Medical Daily · Jul 29

Researchers Mapped the Protein Changes Inside Pancreatic Lesions Years Before They Turn into Cancer

A Cancer Discovery study mapped protein changes in precancerous pancreatic lesions. What it found, and what it cannot yet do.

Medical Daily · Jul 29

FDA Approves an At-Home Injector for the Diuretic That Usually Means a Trip to the Emergency Room

The FDA approved Furoscix ReadyFlow, an at-home furosemide autoinjector for fluid overload in heart failure and kidney disease.

Medical Daily · Jul 29

Four in Ten Americans Are Eating Less Produce Because of the Cyclospora Outbreak, and the Recall Never Covered Most of It

A poll found that 40% of US adults are eating less produce after the Cyclospora outbreak. Here is what the recall actually covers.

Medical Daily · Jul 29

Baxter Recalls a Lot of Cefazolin, the Antibiotic Most Often Used to Prevent Surgical Infections

Baxter recalled one lot of Cefazolin in Dextrose Injection after cardboard particles were found. Why it matters for surgery patients.

Medical Daily · Jul 29

Lettuce Supplier Met Privately with White House Officials as Federal Cyclospora Investigation Named Its Product

Taylor Farms met privately with White House and FDA officials during the cyclospora investigation, a source told Reuters. Here is what is verified.

1 … 45 46 47 48

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Taylor Farms de Mexico

29 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.